0001193125-17-104041 Sample Contracts

Orexigen Therapeutics, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement

Orexigen Therapeutics, Inc. • March 30th, 2017 • Pharmaceutical preparations • New York

• Company
  Orexigen Therapeutics, Inc.
• Filed
  March 30th, 2017
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Orexigen Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: